Evaluating Weight Loss Efficacy in Obesity Treatment with Allurion’s Ingestible Gastric Balloon: A Retrospective Study Utilizing the Scale App Health Tracker DOI Creative Commons

Dănuț Dejeu,

Paula Dejeu,

Paula Bradea

et al.

Clinics and Practice, Journal Year: 2024, Volume and Issue: 14(3), P. 765 - 778

Published: May 6, 2024

Obesity represents a growing public health concern, affecting more than 15% of the global adult population and involving multi-billion market that comprises nutritional, surgical, psychological, multidisciplinary interventions. The objective this retrospective study was to evaluate short-term efficacy body weight measurements associated with differing levels physical activity following use Allurion’s ingestible gastric balloon designed increase feelings fullness decrease food consumption, being naturally eliminated after approximately 16 weeks. This involved 571 individuals who qualified for intervention older 20 years mass index (BMI) 27 kg/m2 or more. Utilizing Scale App Health Tracker smartwatch, able track vital signs in real time. participants had an average initial BMI 34.1 median age 41 years. Notable outcomes were observed both groups, “Less Active” “More Active”, which classified by achieving less number 8000 daily steps. Specifically, fat percentage saw reduction from 33.1 ± 9.4 28.3 10.2 active group 32.2 27.5 group, groups statistical significance (p < 0.001). Additionally, there significant weight, dropping 98.2 22.8 kg 84.6 19.3 97.7 21.0 82.1 22.9 (both p Interestingly, those also experienced lean compared their counterparts = 0.045), although no substantial differences loss, reduction, total between two groups. investigation confirms hypothesis significantly reduces short term enhances several metrics, demonstrating effectiveness as autonomous method challenging management, regardless level activity.

Language: Английский

Evaluating Weight Loss Efficacy in Obesity Treatment with Allurion’s Ingestible Gastric Balloon: A Retrospective Study Utilizing the Scale App Health Tracker DOI Creative Commons

Dănuț Dejeu,

Paula Dejeu,

Paula Bradea

et al.

Clinics and Practice, Journal Year: 2024, Volume and Issue: 14(3), P. 765 - 778

Published: May 6, 2024

Obesity represents a growing public health concern, affecting more than 15% of the global adult population and involving multi-billion market that comprises nutritional, surgical, psychological, multidisciplinary interventions. The objective this retrospective study was to evaluate short-term efficacy body weight measurements associated with differing levels physical activity following use Allurion’s ingestible gastric balloon designed increase feelings fullness decrease food consumption, being naturally eliminated after approximately 16 weeks. This involved 571 individuals who qualified for intervention older 20 years mass index (BMI) 27 kg/m2 or more. Utilizing Scale App Health Tracker smartwatch, able track vital signs in real time. participants had an average initial BMI 34.1 median age 41 years. Notable outcomes were observed both groups, “Less Active” “More Active”, which classified by achieving less number 8000 daily steps. Specifically, fat percentage saw reduction from 33.1 ± 9.4 28.3 10.2 active group 32.2 27.5 group, groups statistical significance (p < 0.001). Additionally, there significant weight, dropping 98.2 22.8 kg 84.6 19.3 97.7 21.0 82.1 22.9 (both p Interestingly, those also experienced lean compared their counterparts = 0.045), although no substantial differences loss, reduction, total between two groups. investigation confirms hypothesis significantly reduces short term enhances several metrics, demonstrating effectiveness as autonomous method challenging management, regardless level activity.

Language: Английский

Citations

2